Publications & Works

Articles 156
All (156)
SCI-E, SSCI, AHCI (129)
SCI-E, SSCI, AHCI, ESCI (137)
ESCI (4)
Scopus (151)
TRDizin (25)
Other Publications (3)
Papers Presented at Peer-Reviewed Scientific Conferences 61

2. Primer antikor eksikliği olan hastalarda intestinal T hücre immünofenotiplendirmesi ve hücre içi sitokin profilleri: Enteropati patogenezi açısından önemi.

XXXI. Uluslararası Katılımlı Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 26–30 Kasım 2025., 26 November 2025, (Summary Text)

10. Spontan İntrahepatik Portosistemik Venöz Şant Olgusu

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.670, (Full Text)

11. Can Portopulmonary Hypertension and Hepatopulmonary Syndrome Coexist?

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.458, (Summary Text)

12. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Turkey, 1 - 05 November 2023, pp.635, (Summary Text)

13. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023, (Summary Text)

15. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Digestive Disease Week 2023, Washington, United States Of America, 6 - 09 May 2023, pp.774, (Summary Text)

16. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 22 - 27 November 2022, pp.1159-1162, (Summary Text)

18. GASTROİNTESTİNAL KANAMA İLE BAŞVURAN RENAL HÜCRELİ KARSİNOM OLGUSU

24. ULUSAL KANSER KONGRESİ, İstanbul, Turkey, 9 - 13 November 2022, pp.1-2, (Summary Text)

19. A RARE CAUSE OF HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: VISCERAL LEISHMANIASIS

24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.118-119, (Full Text) Sustainable Development

22. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

21. Çapa Gastroenteroloji Günleri, İstanbul, Turkey, 31 March - 02 April 2022, pp.70, (Full Text)

24. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219, (Summary Text) Sustainable Development

28. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text) Sustainable Development

29. Is belching increasing after bariatric by-pass surgery in the long term period?

United European Gastroenterology (UEG) Week 2019, Spain, 19 - 23 October 2019, vol.7, pp.703, (Summary Text)

32. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

11. Ulusal Hepatoloji Kongresi, Antalya, Turkey, 17 - 21 May 2017, pp.31-32, (Summary Text)

37. Belching in irritable bowel syndrome: an impedance study

NeuroGASTRO Conference, İstanbul, Turkey, 4 - 06 June 2015, pp.38-39, (Summary Text)

40. The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience

55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, United States Of America, 3 - 06 May 2014, vol.146, (Summary Text)

41. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada, 9 - 13 April 2014, (Summary Text)

42. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text)

43. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands, 24 - 28 April 2013, (Summary Text)

44. HBsAg CLEARENCE AFTER LONG-TERM FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALPHA AND NUCLEOS(T)IDE ANALOGUES

44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen, Denmark, 22 - 26 April 2009, (Summary Text)

46. The presence of HCVRNA in the peripheral blood mononuclear cells of the individuals with isolated anti HCV positivity: Is HCV hiding out?

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, Italy, 23 - 27 April 2008, (Summary Text) Sustainable Development

47. Electron microscopic findings in now alcoholic fatty liver disease; Is there any difference between hepatosteatosis and steatohepatitis?

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, Italy, 23 - 27 April 2008, vol.48, (Summary Text)

49. High baseline HBV-DNA is linked to the emergence of adefovir resistance in lamivudine resistant patients

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain, 11 - 15 April 2007, vol.46, (Summary Text)

50. Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy

56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 11 - 15 November 2005, (Summary Text)

51. Hepatosteatosis in patients with chronic hepatitis B:: Prevalence and the effect on the treatment response rate to α-interferon

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 13 - 17 April 2005, pp.241-242, (Summary Text)

52. The effects of roziglitazone, metformine and diet with exercise in nonalcoholic fatty liver disease

39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Germany, 14 - 18 April 2004, pp.167, (Summary Text)

53. Long term results of alpha-interferon monotherapy

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, pp.149, (Summary Text)

54. Autoimmune hepatitis; What factors predict the response to combination therapy of azathioprine plus steroid

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text) Sustainable Development

55. Sexual transmission of HCV between spouses

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.176, (Summary Text)

56. Are ascitic fluid cholesterol and ratio of ascites/serum cholesterol able to reflect hepatic sinusoidal capillarization?

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.57-58, (Summary Text)

57. Are there any noninvasive markers for diagnosis of viral hepatitis?

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, pp.110, (Summary Text)

58. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text)

59. Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, (Summary Text)

60. The preliminary results of interferon alpha and ribavirin combination therapy in chronic delta hepatitis.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, (Summary Text)

61. Management of non neurojenik bladder (Hinman Syndrome)

5th. Mediterranean Congress of Urology, Barcelona, Spain, 20 - 23 March 1997, vol.Abs Book, pp.391-395, (Summary Text)
Books 1

1. KOMA

in: ACİL DAHİLİYE, CALANGU S, GULER K, Editor, Nobel Tıp Kitabevleri Ltd. Şti., İstanbul, pp.677-694, 2009
Metrics

Publication

218

Publication (WoS)

164

Publication (Scopus)

151

Citation (WoS)

1623

H-Index (WoS)

23

Citation (Scopus)

1955

H-Index (Scopus)

26

Citation (Scholar)

4

H-Index (Scholar)

1

Citation (TrDizin)

1

H-Index (TrDizin)

1

Citation (Sum Other)

1

Project

1

Thesis Advisory

8

Open Access

7
UN Sustainable Development Goals